RxDoctor Payments Data

Calista Comstock, PA

Physician Assistant · Kennewick, WANPI 1720240401

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $5,230 of the $7,090 with a category attached, or 73.8%. 7 manufacturers reported payments, led by Abbott at 38.2% of the total. Reporting peaked in 2023 at $4,603 and has fallen 98.0% since, to $93 in 2025. Among physician assistant clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,090in general payments, 2019–2025

Across 53 payments — averaging $133.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Boston Scientific$2K
  • Nevro Corp.$2K
  • Si-bone, Inc.$885
  • Medtronic$267
  • SPR Therapeutics, Inc$37
  • plus $28 from 1 others

What the payments were for

  • Speaking & faculty fees$2704%
  • Travel & lodging$5,23074%
  • Food & beverage$1,59022%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,090 in reported general payments places this provider in the 95th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington

Medicare billing

Part B allowed, 2024
$36,326
Medicare patients
389
Services billed
580

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl35$4,021
Celecoxib25$947
Gabapentin36$601
Pregabalin16$281
Duloxetine Hcl12$181
Meloxicam35$170
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$68
Triazolam15$14

Paid to pharmacies, not to this prescriber.

Other physician assistant in Kennewick

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →